Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 776-800 of 949 matching filings.

Per page
25
Current page
32
4

4 filing

Filing date
23 Apr 2012
Reporting date
20 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Apr 2012
Reporting date
20 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
23 Apr 2012
Reporting date
17 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
13 Apr 2012
Reporting date
10 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35076

CT ORDER filing

Filing date
13 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2012
Reporting date
10 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2012
Reporting date
10 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2012
Reporting date
10 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2012
Reporting date
10 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Apr 2012
Reporting date
10 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-35076

8-K/A

Filing date
11 Apr 2012
Reporting date
09 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
03 Apr 2012
Reporting date
03 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
01 Mar 2012
Reporting date
29 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2012
Reporting date
09 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2012
Reporting date
09 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
16 Feb 2012
Reporting date
10 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
01 Feb 2012
Reporting date
01 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
25 Jan 2012
Reporting date
25 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
20 Jan 2012
Reporting date
01 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
20 Jan 2012
Reporting date
01 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .